Your health is important, and your healthcare provider is there to help you
Compounded GLP-1 medications are not FDA-approved finished drug products they are pharmacy-prepared versions of the same active ingredients used in Wegovy, Ozempic, Mounjaro, and Zepbound, and they have not undergone FDA review for safety, efficacy, or quality as individual products
proposed explanations include direct sinoatrial node effects, changes in autonomic balance with increased sympathetic tone, or reflex changes related to lower blood pressure
Aiming for specific targets can make a huge difference
Looking for financial assistance from nonprofits
Reuters: Novo & Lilly reach pricing deal #GLP1 #CKM #CardioRenalMetabolic #Pharma #Biotech #AIinHealthcare #HealthTech #KidneyCare #ValueBasedCare #Investing To view or add a comment, sign in We were excited to support our partners at Tandem Health on their recently published paper titled Impact of Direct Clinical Pharmacist Intervention on Achievement of Blood Pressure Control at a Federally Qualified Health Center Within a Medically Underserved Area